Fig. 3
From: Increased expression of Six1 correlates with progression and prognosis of prostate cancer
Receiver–operator curve (ROC) analysis for different clinicopathological parameters and Six1 expression was used to evaluate the survival status. clinical stage (AUC = 0.626, P = 0.019), Gleason_score (AUC = 0.643, P = 0.008), T stage (AUC = 0.626, P = 0.019), N stage (AUC = 0.644, P = 0.007), Six1 expression (AUC = 0.674, P = 0.001) implied significant statistical associations with the survival